Medicinal Chemistry Journal of Medicinal Chemistry

RL linker designer yields oral covalent FGFR4 degrader

  • PotentialLinker is a reinforcement-learning tool that optimizes PROTAC linkers, scoring candidates by predicted degradation potential without needing precomputed protein-protein complexes.
  • Retrospective STAT3 and RIPK1 case studies recapitulated known linker SAR trends and pointed to suitable E3 ligases.
  • Prospectively it produced FGFR4 degrader D11, which engages Cys552 covalently, degrades selectively, and shows oral exposure plus tumor suppression in vivo with acceptable tolerability.
Points Based on the abstract

Covalency on Cys552, a residue unique to FGFR4 within the FGFR family, probably drives selectivity more than the linker does. What's missing is a head-to-head with the non-degrading covalent warhead: if that is equally effective in vivo, the degrader premium is unproven. Oral exposure is rare for PROTACs, so I'd want the full PK.